Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study.
Tran H, von Mackensen S, Abraham A, Castaman G, Hampton K, Knoebl P, Linari S, Odgaard-Jensen J, Neergaard JS, Stasyshyn O, Thaung Zaw JJ, Zulfikar B, Shapiro A. Tran H, et al. Among authors: neergaard js. Res Pract Thromb Haemost. 2024 Jun 17;8(4):102476. doi: 10.1016/j.rpth.2024.102476. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39099801 Free PMC article.
The Concizumab Pen-Injector is Easy to Use and Preferred by Hemophilia Patients and Caregivers: A Usability Study Assessing Pen-Injector Handling and Preference.
Kahr Rasmussen N, Berg B, Christiansen ASL, Neergaard JS, Ter-Borch G, Hildebrand EA, Gonczi M, Sparre T. Kahr Rasmussen N, et al. Among authors: neergaard js. Patient Prefer Adherence. 2024 Aug 14;18:1713-1727. doi: 10.2147/PPA.S470091. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39161804 Free PMC article.
Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections.
Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK. Akhtar S, et al. Among authors: neergaard js. Med Devices (Auckl). 2024 Oct 30;17:427-439. doi: 10.2147/MDER.S484354. eCollection 2024. Med Devices (Auckl). 2024. PMID: 39493440 Free PMC article.
Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women.
Bertelsen DM, Neergaard JS, Bager CL, Nielsen SH, Secher NH, Svendsen JH, Bihlet AR, Andersen JR, Karsdal MA, Christiansen C, Nielsen HB. Bertelsen DM, et al. Among authors: neergaard js. Sci Rep. 2018 Mar 29;8(1):5371. doi: 10.1038/s41598-018-23458-4. Sci Rep. 2018. PMID: 29599489 Free PMC article.
Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer.
Willumsen N, Bager CL, Kehlet SN, Dragsbaek K, Neergaard JS, Hansen HB, Bay-Jensen AC, Leeming DJ, Lipton A, Christiansen C, Karsdal M. Willumsen N, et al. Among authors: neergaard js. Oncotarget. 2017 Feb 11;8(32):52501-52510. doi: 10.18632/oncotarget.15275. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881747 Free PMC article.
17 results